OneMedNet Corp (ONMD): Operating Income

Annual figures by period end, from SEC filings.

-$9.67M

Year ended 2025-12-31

-$10.13M

Trailing 12 months to 2026-06-30

2022-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$9.67M	n/m	2026-03-30, From 2025-01-01
2024-12-31	-$9.61M	n/m	2026-03-30, From 2024-01-01
2023-12-31	-$6.85M	n/m	2025-04-15, From 2023-01-01
2022-12-31	-$7.71M	n/a	2024-11-05, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
OneMedNet Corp (ONMD)	2025-12-31	-$9.67M	n/m
iSpecimen Inc. (ISPC)	2025-12-31	-$8.98M	n/m
Absci Corp (ABSI)	2025-12-31	-$120.32M	n/m
Cannabis Bioscience International Holdings, Inc. (CBIH)	2025-05-31	-$421.4K	n/m
bioAffinity Technologies, Inc. (BIAF)	2025-12-31	-$10.57M	n/m
Foxo Technologies Inc. (FOXO)	2025-12-31	-$10.33M	n/m
OmniAb, Inc. (OABI)	2025-12-31	-$68.97M	n/m
MaxCyte, Inc. (MXCT)	2025-12-31	-$51.90M	n/m
NRC Health (NRC)	2025-12-31	$22.59M	-35.8%

Compare ONMD, ISPC, ABSI, CBIH side by side · Screen every company in Services-Commercial Physical & Biological Research ↗